Control of microglial neurotoxicity by the fractalkine receptor
about
CX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticityCX3CR1 is a modifying gene of survival and progression in amyotrophic lateral sclerosisRecent research on Gulf War Illness and other health problems in veterans of the 1991 Gulf War: effects of toxicant exposures during deploymentPericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain agingTherapeutic potential of perineural invasion, hypoxia and desmoplasia in pancreatic cancerCNS immune privilege: hiding in plain sight.CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for NeuroprotectionMicroglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson's Disease-Lessons from Transgenic MiceSystematic Review of the Neurobiological Relevance of Chemokines to Psychiatric DisordersFractalkine Signaling and Microglia Functions in the Developing BrainNeuroinflammation in Parkinson's disease and its potential as therapeutic targetAging-related changes in neuroimmune-endocrine function: implications for hippocampal-dependent cognitionWhen and how do seizures kill neurons, and is cell death relevant to epileptogenesis?Surveillance, phagocytosis, and inflammation: how never-resting microglia influence adult hippocampal neurogenesisThe "quad-partite" synapse: microglia-synapse interactions in the developing and mature CNSCellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's diseaseInnate immunity in the central nervous systemBrain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid systemFrom development to dysfunction: microglia and the complement cascade in CNS homeostasisReceptors, ion channels, and signaling mechanisms underlying microglial dynamicsThe microglial-motoneuron dialogue in ALSNeurotrauma and inflammation: CNS and PNS responsesAnimal models of age related macular degenerationContributions of nonhematopoietic cells and mediators to immune responses: implications for immunotoxicologyMicroglia centered pathogenesis in ALS: insights in cell interconnectivityAlterations in immune cells and mediators in the brain: it's not always neuroinflammation!Neurogenesis, inflammation and behaviorThe role of microglia in adult hippocampal neurogenesisM1 and M2 immune activation in Parkinson's Disease: Foe and ally?Bidirectional microglia-neuron communication in the healthy brainMicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNSReactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain.Differential modulation of retinal degeneration by Ccl2 and Cx3cr1 chemokine signallingThe neuron-astrocyte-microglia triad in normal brain ageing and in a model of neuroinflammation in the rat hippocampusFunctional classification of memory CD8(+) T cells by CX3CR1 expression.AAV-dominant negative tumor necrosis factor (DN-TNF) gene transfer to the striatum does not rescue medium spiny neurons in the YAC128 mouse model of Huntington's diseaseLy6c+ "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitisThe Indispensable Roles of Microglia and Astrocytes during Brain DevelopmentNeuron-Microglia Interactions in Mental Health Disorders: "For Better, and For Worse"Immunomodulators as Therapeutic Agents in Mitigating the Progression of Parkinson's Disease
P2860
Q21129473-8CCBA3B4-B818-4BB9-B39F-32297B1B9163Q21132045-983E7134-E0FD-42D3-8590-726BA7B50F8DQ23920396-383B8472-9C76-41F1-9099-12B09C17FED2Q24600644-B7DD9FE5-01C3-4D9F-A688-6C94DDA5590DQ24621214-12750E57-4E02-465E-B210-B5D18AE4433BQ24642697-764B0412-242A-4038-8B9E-CBDF1960166FQ26739374-9060F817-0283-46DE-A789-FA5DC9AFBDD9Q26773064-FC13F594-44B1-468E-A865-415637884DC3Q26781639-4FB660F2-D6B9-4474-AB26-3514A2A75605Q26782935-F8C7BB36-86F9-4975-A5F6-AFF52C42607BQ26783305-727D31D3-8F12-4ED4-B748-678CF6A84B47Q26824043-EECACA1A-A5EC-4750-BB95-D15C29FDE4A2Q26824190-5EDF4D3B-E192-4AB0-AE83-CD119730D856Q26824282-3DD1C755-4FCF-46B5-9E4E-3B1434084120Q26825543-D92801BD-432B-44A3-A5D2-7FB1CEC294F5Q26849232-08B51A84-B7A9-47EE-9D2C-F5FD62E24312Q26858882-6117DAC1-5478-4468-A8F3-74DB91CDBF86Q26865295-5B447957-3795-4048-B2AA-834690294EDAQ26865892-411AB87C-664A-45A5-A3A1-750048E6B9CDQ26998908-263EE25A-14BC-4641-B881-AA91A3B78608Q27000470-829E0902-DDC4-4AA4-9075-20A665706B18Q27001219-93114B15-C19D-43D7-971C-E91E5B3F0F7DQ27004686-70E3D357-7D28-49F3-8665-BBC785202475Q27005695-8E17DBCB-D9EC-4197-BDB0-ABA804112F3BQ27009559-7753394E-BA02-41D5-A58B-34EE3D831706Q27010652-84BA01EF-2CC9-429D-BA33-B6F80B7F6429Q27016122-D3F66990-5C19-4F0E-84CB-40907B484EC6Q27023194-CDAC3644-37B0-4E3C-974F-C5F86D2362A1Q27024667-0FA445DD-2FB5-4804-A930-6569BE5A2F16Q27024873-4D4D1312-FABF-4BF8-B576-C8C2886CCAFBQ27025394-C72A7EC6-9062-4EE5-8C41-3BEDF10EA9B8Q27303769-D8EE31F7-32A0-41B9-8194-8350E02E72A1Q27304365-DF179519-F3E7-491F-916A-733088B5CE04Q27318419-FAED9C9B-DC89-41C2-ABDF-DF47AFC39938Q27322730-8D0FBD2B-9CF5-4DEF-A033-44A876AF0C55Q27334472-60B54BD4-9DA6-4E4D-9657-E2C3A8C0DCD0Q27486985-72D0E8F7-7167-4DEE-B145-2B02A4B58DDBQ28067530-8F13CBE9-2C2B-463D-A622-71195321B4B1Q28076010-A68A7AB8-F303-4B0D-A81B-86C9E122AE61Q28079187-4ADDB65F-AD89-4401-8B6B-53A7C4AB81B3
P2860
Control of microglial neurotoxicity by the fractalkine receptor
description
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im Juli 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2006/07/01)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/07/01)
@nl
наукова стаття, опублікована в липні 2006
@uk
مقالة علمية (نشرت في يوليو 2006)
@ar
name
Control of microglial neurotoxicity by the fractalkine receptor
@ast
Control of microglial neurotoxicity by the fractalkine receptor
@en
Control of microglial neurotoxicity by the fractalkine receptor
@nl
type
label
Control of microglial neurotoxicity by the fractalkine receptor
@ast
Control of microglial neurotoxicity by the fractalkine receptor
@en
Control of microglial neurotoxicity by the fractalkine receptor
@nl
prefLabel
Control of microglial neurotoxicity by the fractalkine receptor
@ast
Control of microglial neurotoxicity by the fractalkine receptor
@en
Control of microglial neurotoxicity by the fractalkine receptor
@nl
P2093
P3181
P356
P1433
P1476
Control of microglial neurotoxicity by the fractalkine receptor
@en
P2093
Astrid E. Cardona
Dan R. Littman
Deren Huang
Donald N. Cook
Erik P. Pioro
Grahame Kidd
Ineke M. Dijkstra
Jar-Chi Lee
Margaret E. Sasse
RanJan Dutta
P2888
P304
P3181
P356
10.1038/NN1715
P407
P577
2006-07-01T00:00:00Z
P5875
P6179
1021332650